Davidson Kempner Capital Management »

Cytokinetics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 203k 52.79
2024-06-30 $6.8M 126k 54.07
2024-03-31 $2.6M 37k 70.06

More positions owned by Davidson Kempner Capital Management

Arko Corp (ARKO)
Pdd Holdings Note 12/0 (Principal)
Freshpet Note 3.000% 4/0 (Principal)
Meta Platforms Cl A (META)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Western Digital (WDC)
Wayfair Note 3.250% 9/1 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Playa Hotels & Resorts Nv SHS (PLYA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Metropcs Communications (TMUS)
Teck Resources CL B (TECK)
Iqiyi Note 6.500% 3/1 (Principal)
Mara Holdings Note 1.000%12/0 (Principal)
Li Auto Note 0.250% 5/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
Bank of America Corporation
Armistice Capital
T. Rowe Price Associates
Geode Capital Management
Rtw Investments
Polar Capital Holdings
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA

View all funds holding Cytokinetics